TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32393215

Group type: EXPERIMENTAL
Intervention: Revefenacin 175 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35908570

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 32535600

Group type: EXPERIMENTAL
Intervention: HBO + pharmacological treatment (HBO+P)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Pharmacological treatment (P)
Number of subjects: 136
Study: 32828994

Group type: EXPERIMENTAL
Intervention: Primary lip surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fathers with bilateral CLP infants
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Parents with local anesthesia experience
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Maternal age
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paternal age
Number of subjects: 80
Study: 36066123

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 or 300mg every 2 weeks
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 32895918

Group type: EXPERIMENTAL
Intervention: Short-sleep duration
Number of subjects: 367586

Group type: EXPERIMENTAL
Intervention: Long-sleep duration
Number of subjects: 367586
Study: 32350931

Group type: EXPERIMENTAL
Intervention: Home-based minimally supervised exercise program (exercise on a stationary cycle and strengthening of upper limbs; stretching of the hands)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Home-based minimally supervised exercise program
Number of subjects: 44
Study: 35522281

Group type: EXPERIMENTAL
Intervention: 6-month web-based group-coaching program (Better Together Physician Coaching)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (residency training as usual)
Number of subjects: 101
Study: 33861329

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (n = 91); 12 weekly 90-minute group sessions.
Number of subjects: 184

Group type: COMPARATOR
Intervention: Cognitive processing therapy (n = 93); 12 weekly 90-minute group sessions.
Number of subjects: 184
Study: 35307465

Group type: EXPERIMENTAL
Intervention: ADD group (pecans 68 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (nut-free)
Number of subjects: 16
Study: 34732491

Group type: EXPERIMENTAL
Intervention: Duloxetine treatment (60 mg/day for 7 weeks)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care (no additional treatment)
Number of subjects: 111
Study: 34287493

Group type: EXPERIMENTAL
Intervention: Conventional treatment and adjuvant laser therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 38
Study: 32739310

Group type: EXPERIMENTAL
Intervention: Prehabilitation program (4-week supervised preoperative exercise training)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Prehabilitation program
Number of subjects: 54
Study: 36215044

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) with medical therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 202
Study: 33529266

Group type: EXPERIMENTAL
Intervention: COVID-19 publications (76 total)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Non-COVID publications (154 in 2020, 172 in 2019)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: COVID-19 publications
Number of subjects: 402
Study: 35687757

Group type: EXPERIMENTAL
Intervention: Sutimlimab
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32964565

Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: SCIG
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: IVIG and SCIG
Number of subjects: 34
Study: 32329184

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 36159280

Group type: EXPERIMENTAL
Intervention: Nomogram developed using training group data; validated in validation group.
Number of subjects: 2716

Group type: COMPARATOR
Intervention: High-risk group based on nomogram predictions.
Number of subjects: 2716

Group type: EXPERIMENTAL
Intervention: Nomogram predictive performance in training group.
Number of subjects: 2716

Group type: EXPERIMENTAL
Intervention: Nomogram predictive performance in validation group.
Number of subjects: 2716

Group type: EXPERIMENTAL
Intervention: Calibration slopes of nomogram in training and validation groups.
Number of subjects: 2716
Study: 33874803

Group type: EXPERIMENTAL
Intervention: Full bandwidth direct drive hearing aids
Number of subjects: 15

Group type: COMPARATOR
Intervention: Narrow bandwidth direct drive hearing aids
Number of subjects: 15
Study: 32292093

Group type: EXPERIMENTAL
Intervention: Dacomitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 0
Study: 33010473

Group type: EXPERIMENTAL
Intervention: ETC + Patient Navigation (up to 10 h of navigation over a 3-month period)
Number of subjects: 44

Group type: COMPARATOR
Intervention: ETC (list of smoking cessation resources)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ETC + Patient Navigation
Number of subjects: 44
Study: 36356037

Group type: EXPERIMENTAL
Intervention: 600 IU vitamin D3 + 500 mg calcium
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 1200 IU vitamin D3 + 500 mg calcium
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 4000 IU vitamin D3 + 500 mg calcium
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (500 mg calcium)
Number of subjects: 106
Study: 32640854

Group type: EXPERIMENTAL
Intervention: Active iTBS
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham iTBS
Number of subjects: 39
Study: 32772268

Group type: EXPERIMENTAL
Intervention: PICSI
Number of subjects: 413

Group type: COMPARATOR
Intervention: MACS
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: MACS (females < 30 years)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: PICSI (females 30-35 years)
Number of subjects: 413
Study: 36481988

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation orally starting from 14 weeks gestation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 100
Study: 36435474

Group type: EXPERIMENTAL
Intervention: Gummy candy enriched with 250 mg of Konjac glucomannan (KGM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo candy with 250 mg of flaxseed meal
Number of subjects: 42
Study: 33471404

Group type: EXPERIMENTAL
Intervention: Mindful Self-Compassion program (MSC)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Cognitive-Behavioural Therapy (CBT)
Number of subjects: 123
Study: 32555029

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34656873

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 32791881

Group type: EXPERIMENTAL
Intervention: Early specialist palliative care (SPC)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 174
Study: 34132492

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 7020

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 7020

Group type: EXPERIMENTAL
Intervention: Empagliflozin (pooled doses)
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 33143203

Group type: EXPERIMENTAL
Intervention: Micronutrient fortified meal (570 kcal) in the form of a bar and shake containing >75% of the FDA Daily Values for all essential vitamins and minerals
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control meal (usual meal provided)
Number of subjects: 35
Study: 33716963

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 15
Study: 32207718

Group type: EXPERIMENTAL
Intervention: Xeomin (up to 800 U)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined therapy of xeomin and baclofen (10 mg 3 times a day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Xeomin (monotherapy)
Number of subjects: 96
Study: 35618380

Group type: EXPERIMENTAL
Intervention: Paired coaching
Number of subjects: 252

Group type: COMPARATOR
Intervention: Individual coaching
Number of subjects: 252

Group type: COMPARATOR
Intervention: Non-coached conditions
Number of subjects: 252
Study: 34362266

Group type: EXPERIMENTAL
Intervention: Caregiver Skills Training (n = 43)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Treatment as usual (n = 43)
Number of subjects: 86
Study: 36399201

Group type: EXPERIMENTAL
Intervention: Underwater cold snare polypectomy
Number of subjects: 398

Group type: COMPARATOR
Intervention: Conventional cold snare polypectomy
Number of subjects: 398
Study: 36337273

Group type: EXPERIMENTAL
Intervention: Lycopene (25 mg once a day for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (starch tablets once a day for 8 weeks)
Number of subjects: 50
Study: 34020976

Group type: EXPERIMENTAL
Intervention: Financial counselling
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual care plus information from a government money advice website
Number of subjects: 180
Study: 35075752

Group type: EXPERIMENTAL
Intervention: Ablative fractional CO2 laser combined with autologous platelet-rich plasma (PRP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ablative fractional CO2 laser and placebo (plain normal saline solution)
Number of subjects: 16
Study: 33032897

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study: 34183640

Group type: EXPERIMENTAL
Intervention: iTBS (1 week of iTBS/2 weeks of sham, 2 weeks of iTBS/1 week of sham, or 3 weeks of iTBS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: iTBS (G₁₋₃ combined)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham (G₀)
Number of subjects: 36
Study: 33248596

Group type: EXPERIMENTAL
Intervention: Glucose-based purified diet
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Experimental diets with 957 g/kg inclusion of grains (corn, sorghum, wheat, barley)
Number of subjects: 48
Study: 35777931

Group type: EXPERIMENTAL
Intervention: Extrafascial injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intrafascial injection
Number of subjects: 50
Study: 33539971

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to adjuvant chemotherapy
Number of subjects: 1501

Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 1501

Group type: COMPARATOR
Intervention: Former smokers
Number of subjects: 1501

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 1501

Group type: COMPARATOR
Intervention: Nonsmokers at enrollment
Number of subjects: 1501

Group type: EXPERIMENTAL
Intervention: Respondents at 12 months
Number of subjects: 1501
Study: 32951746

Group type: EXPERIMENTAL
Intervention: Oak Gall vaginal cream
Number of subjects: 84

Group type: COMPARATOR
Intervention: Metronidazole vaginal gel
Number of subjects: 84
Study: 33477151

Group type: EXPERIMENTAL
Intervention: Imagery Rescripting
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Imaginal Exposure
Number of subjects: 96

Group type: COMPARATOR
Intervention: Positive Imagery
Number of subjects: 96
Study: 32227140

Group type: EXPERIMENTAL
Intervention: Long-term exposure to PM2.5 (0.88 μg/m3 increase)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Long-term exposure to NOx (8.35 μg/m3 increase)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Heart failure (PM2.5 exposure)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Heart failure (NOx exposure)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Ischemic heart disease (PM2.5 exposure)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Ischemic heart disease (NOx exposure)
Number of subjects: 2927

Group type: EXPERIMENTAL
Intervention: Stroke as an intermediate condition
Number of subjects: 2927
Study: 35350937

Group type: EXPERIMENTAL
Intervention: Lasmiditan (50 mg, 100 mg, or 200 mg)
Number of subjects: 7920

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7920
Study: 33377146

Group type: EXPERIMENTAL
Intervention: Presence of a sweepstakes offer
Number of subjects: 5244

Group type: EXPERIMENTAL
Intervention: Outdoors settings, flora imagery, natural descriptors, and environmental themes
Number of subjects: 5244

Group type: EXPERIMENTAL
Intervention: Price reductions (e.g., coupons)
Number of subjects: 5244
Study: 35129520

Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis
Number of subjects: 89

Group type: COMPARATOR
Intervention: Extracorporeal anastomosis
Number of subjects: 89
Study: 33969592

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg, daily)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 19
Study: 36123374

Group type: EXPERIMENTAL
Intervention: Bambara groundnut genotypes
Number of subjects: 30
Study: 34354179

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg QD
Number of subjects: 20

Group type: COMPARATOR
Intervention: simvastatin 40 mg combined with ezetimibe 10 mg QD
Number of subjects: 20
Study: 32696603

Group type: EXPERIMENTAL
Intervention: Savoring an exciting memory
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Savoring a calm memory
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Control condition (what they did today and yesterday)
Number of subjects: 1238
Study: 32346779

Group type: EXPERIMENTAL
Intervention: Two suture-button systems (group A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: One suture-button system and an autologous gracilis tendon graft (group B)
Number of subjects: 36
Study: 32109848

Group type: EXPERIMENTAL
Intervention: High intratumoral DC-SIGN+ macrophages infiltration
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: High infiltration of DC-SIGN+ macrophages
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: CD8+ T cells in DC-SIGN+ macrophages high subgroup
Number of subjects: 504
Study: 35442613

Group type: EXPERIMENTAL
Intervention: PIBI+CI
Number of subjects: 74

Group type: COMPARATOR
Intervention: CI
Number of subjects: 74

Group type: COMPARATOR
Intervention: PIBI
Number of subjects: 74
Study: 33713522

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) using Hair Growth System (TOPHAT655) for 20 minutes, two sessions per week for 16 weeks (total of 32 treatments).
Number of subjects: 20
Study: 34357723

Group type: EXPERIMENTAL
Intervention: Transillumination method
Number of subjects: 450

Group type: COMPARATOR
Intervention: Visual inspection
Number of subjects: 450
Study: 32407638

Group type: EXPERIMENTAL
Intervention: Bronchial rheoplasty
Number of subjects: 30
Study: 36163181

Group type: EXPERIMENTAL
Intervention: Clinician champion intervention
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Qualitative thematic analysis of clinician champions' documentation
Number of subjects: 2
Study: 33770169

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to higher risk of T2D
Number of subjects: 133010

Group type: EXPERIMENTAL
Intervention: Higher levels of fasting insulin
Number of subjects: 133010

Group type: EXPERIMENTAL
Intervention: Fasting insulin
Number of subjects: 133010
Study: 32932881

Group type: EXPERIMENTAL
Intervention: Plant Milking Technology applied to Morus alba L. (mulberry tree)
Number of subjects: 0
Study: 35444013

Group type: EXPERIMENTAL
Intervention: Dostarlimab as maintenance therapy after chemoradiation
Number of subjects: 132

Group type: COMPARATOR
Intervention: Clinical and radiological follow-up (control)
Number of subjects: 132
Study: 34836020

Group type: EXPERIMENTAL
Intervention: HMB-enriched oral nutritional supplements (ONS) - 220 mL of Ensure® Plus Advance, twice a day for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: HP oral nutritional supplements (ONS) - 220 mL of Ensure® Plus High Protein, twice a day for 12 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both treatments (HMB and HP)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: HMB-enriched ONS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MHE evaluation
Number of subjects: 43
Study: 32106777

Group type: EXPERIMENTAL
Intervention: Revefenacin 175 µg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tiotropium 18 µg
Number of subjects: 0
Study: 35325513

Group type: EXPERIMENTAL
Intervention: Highest quartile of percentage of energy intake from ultra-processed foods (PEI-UPF)
Number of subjects: 156
Study: 34526061

Group type: EXPERIMENTAL
Intervention: Support mechanisms for research generation and utilization (self‐administered cross‐sectional survey using m‐SATORI)
Number of subjects: 258
Study: 35776203

Group type: EXPERIMENTAL
Intervention: 35% HP with applicator brush
Number of subjects: 40

Group type: COMPARATOR
Intervention: 35% HP without applicator brush
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 37.5% HP with applicator brush
Number of subjects: 40

Group type: COMPARATOR
Intervention: 37.5% HP without applicator brush
Number of subjects: 40
Study: 33554391

Group type: EXPERIMENTAL
Intervention: Genetic counseling with prior education via a Web platform
Number of subjects: 120

Group type: COMPARATOR
Intervention: Genetic counseling without additional education
Number of subjects: 120
Study: 34933146

Group type: EXPERIMENTAL
Intervention: Double layered purse string uterine suture (PSUS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single layer continuous uterine suture (SLCUS)
Number of subjects: 100
Study: 35638576

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation therapy using mobile applications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34117184

Group type: EXPERIMENTAL
Intervention: Combined upper limb exercise training (ULET)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Strength upper limb exercise training (ULET)
Number of subjects: 36
Study: 32846388

Group type: EXPERIMENTAL
Intervention: Self-compassion meditations
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nature-focused guided imagery meditations
Number of subjects: 70
Study: 32643473

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP) injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical erythromycin 2%
Number of subjects: 40
Study: 35770300

Group type: EXPERIMENTAL
Intervention: ART FILLER® Volume
Number of subjects: 0

Group type: COMPARATOR
Intervention: Juvéderm Voluma®
Number of subjects: 0
Study: 33402258

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 70

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study: 32235569

Group type: EXPERIMENTAL
Intervention: Soluble Corn Fiber (SCF)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 22
Study: 85198193

Group type: COMPARATOR
Intervention: Placebo group in a hepatitis B vaccine trial
Number of subjects: 236
Study: 36284024

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hot Water Immersion (HWI)
Number of subjects: 18
Study: 33620897

Group type: EXPERIMENTAL
Intervention: Opioid-specific counseling
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 135
Study: 33327405

Group type: EXPERIMENTAL
Intervention: Inertial flywheel (FW) resistance training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Free weight resistance training (TRA)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: FW-strong group
Number of subjects: 28
Study: 35721646

Group type: EXPERIMENTAL
Intervention: ETB inflated with alkalinized lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline solution (control group)
Number of subjects: 60
Study: 32297784

Group type: COMPARATOR
Intervention: No-stress condition
Number of subjects: 39
Study: 33529723

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT) with raw egg white powder, maintenance dose of 1 g of egg white protein for 8 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Avoidance for 6 months followed by crossover to OIT
Number of subjects: 50
Study: 34448547

Group type: EXPERIMENTAL
Intervention: Intravenous ascorbic acid (500 mg) administered 2 hours before colonoscopic resection and on days 2 and 3 post-polypectomy
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group received normal saline
Number of subjects: 153
Study: 34836304

Group type: EXPERIMENTAL
Intervention: High-amylose maize starch (HMS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Native banana starch (NBS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Digestible maize starch (DMS)
Number of subjects: 17
Study: 33362223

Group type: EXPERIMENTAL
Intervention: Neuromuscular strength‐resistance training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Classic strength‐resistance training
Number of subjects: 30
Study: 34275877

Group type: EXPERIMENTAL
Intervention: Standard demand creation augmented by human‐centred design (HCD)‐informed approach
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Standard demand creation plus offer of HIV self‐testing (HIVST)
Number of subjects: 140

Group type: COMPARATOR
Intervention: IPC agents that reported reaching at least one man with demand creation
Number of subjects: 140
Study: 32183859

Group type: EXPERIMENTAL
Intervention: Active training approach (model learning)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Passive training approach (reading manual-based instructions)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Direct supervision technique (supervision based on video analysis)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Indirect supervision technique (supervision based on verbal reporting)
Number of subjects: 68
Study: 36435010

Group type: EXPERIMENTAL
Intervention: Adjunctive brivaracetam (BRV) treatment; median modal dose: 200 mg/day; median treatment duration: 2.67 years
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Adjunctive brivaracetam (BRV) treatment
Number of subjects: 740
Study: 34013444

Group type: EXPERIMENTAL
Intervention: Short-term prophylactic intravenous antibiotics (7 days)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Long-term prophylactic intravenous antibiotics (14 days)
Number of subjects: 180
Study: 32400342

Group type: EXPERIMENTAL
Intervention: Praziquantel mass drug administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control strategies for schistosomiasis
Number of subjects: 0